CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value
      QxMD      Google Scholar   
Citation:
J Immunother Cancer vol 12 (1)
Year:
2024
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
Alliance-data-source,-external-user
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
   
Pharmas:
Bristol-Myers Squibb, Genentech, Pfizer  
Grants:
U10CA180821, U10CA180882, UG1CA233163, UG1CA233373, P30CA 014089, U10CA180888 (SWOG)  
Corr. Author:
 
Authors:
                                                           
Networks:
CA011, CA824, CAPITAL, LAPS-MN026, LAPS-NC007, LAPS-OH007, MN022, SCOR   
Study
Alliance-A152001
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-80405
Phases:
N/A, 3
Keywords:
Immunotherapy, Gastrointestinal Neoplasms, Gene Expression Profiling, Molecular Targeted Therapy, Tumor Biomarkers